Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen

Cancer. 2004 Sep 1;101(5):1100-1; author reply 1101. doi: 10.1002/cncr.20461.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Doxorubicin / therapeutic use*
  • Humans
  • Hyperglycemia / etiology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Remission Induction
  • Time Factors
  • Vincristine / therapeutic use*

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide

Supplementary concepts

  • CVAD protocol